China Domestica Bio (GREY:CDBH)

On February 13, 2012, Qingyu Meng resigned as President and as a member of the Board of Directors of China Domestica Bio-technology Holdings, Inc. (the “Company”). Mr. Meng’s resignation was due to personal reasons and not because of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.

On February 16, 2012, the Board of Directors appointed Mr. Yung Kong Chin as President of the Company effective immediately.

Prior reverse merger plans cancelled:

Whereas sales and marketing activities were our focus during fiscal 2009, we were unable to realize any revenues as a result of these activities. As a result of our lack of revenues and inability to secure additional funding to allow business operations to continue, our Board of Directors determined that it was necessary to terminate the execution of our prior business plan, and that a change in business focus was needed and in the best interests of the Company and its shareholders. The goal of the new business plan is to merge with or acquire a revenue-producing business or a development stage business with a high potential for growth.

Reverse merger transaction with a Chinese pharmaceutical company seems imminent. Target company yet to be disclosed.

see filing